Quantum-Si
Quantum-Si is seeking a highly execution-oriented Director of Business Development & Alliances to establish and manage strategic partnerships that extend their proteomics platform ecosystem. The role involves leading partnership execution from inception to delivery, managing relationships, and driving commercial and scientific growth.
Headquarters
Branford, Connecticut, United States
Company Size
51-200 employees
Founded
2013
Quantum‑Si (The Protein Sequencing Company™) builds single‑molecule protein sequencing systems that bring high‑resolution proteomic analysis to the benchtop. Their platform pairs proprietary instrumentation, chemistry, and software to deliver real‑time, single‑molecule sensitivity and precise quantitative readouts. Quantum‑Si targets applications across biomarker discovery, drug development, translational research, and clinical proteomics, aiming to simplify workflows and accelerate actionable insights for academic, biopharma, and clinical labs.
Research Analysts Issue Forecasts for Quantum-Si Q1 Earnings
1 day ago
Quantum-Si outlines $1M 2026 revenue target and $425,000 Proteus list price as company prepares for major platform transition
3 days ago
Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results
6 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Quantum-Si.
91% above the average for this role
AI Reliance Poses Growing Regulatory and Operational Risks for Quantum-Si
5 days ago